, Volume 13, Issue 3, pp 97–101 | Cite as

Serum antibody response to clostridium difficile toxins in patients with clostridium difficile diarrhoea

  • B. Aronsson
  • M. Granström
  • R. Möllby
  • C. E. Nord


Consecutive serum samples from 61 patients withClostridium difficile diarrhoea were investigated for antibody response toC. difficile toxins A and B in an indirect enzyme immunoassay (ELISA) and in a neutralization assay againstC. difficile cytotoxin. Sera from 64 blood donors, elderly healthy females and patients with other known intestinal enteropathogens served as controls. An immune response was detected by ELISA in approximately half of the patients withC. difficile diarrhoea. The specificity of the ELISA was 94% or 97%, depending on the control material used. Furthermore, a correlation was found between clinical recovery without relapse ofC. difficile diarrhoea and high IgG titers to toxin B in the ELISA, and/or appearance of neutralizing antibodies. It is concluded that the ELISA for detection of serum antibodies toC. difficile toxins may be of diagnostic value in combination with the conventional tissue culture assay for cytotoxin in stool. High ELISA IgG titres to toxin B and/or the appearance of neutralizing antibodies may also be a positive prognostic sign in patients withC. difficile diarrhoea.


Clostridium Clostridium Difficile Serum Antibody Response Clostridium Difficile Toxin Indirect Enzyme 

Serum-Antikörper-Antwort auf Clostridium difficile-Toxine bei Patienten mit Clostridium difficile-Diarrhoe


Von 61 Patienten mitClostridium difficile-Diarrhoe wurden konsekutive Serumproben mit einem indirekten Enzymimmunassay (ELISA) und einem Neutralisationstest fürC. difficile Cytotoxin auf die Antikörperantwort gegen die Toxine A und B vonC. difficile untersucht. Als Kontrollen wurden Seren von 64 Blutspendern, älteren gesunden Frauen und Patienten, die an Krankheiten durch andere bekannte enteropathogene Erreger litten, verwendet. Bei annähernd der Hälfte der Patienten mitC. difficile-Diarrhoe wurde mittels ELISA eine Immunantwort entdeckt. In Abhängigkeit vom Kontrollmaterial ergab sich für den ELISA-Test eine Spezifität von 94% oder 97%. Bei Patienten, die sich ohne Rezidiv von derC. difficile-Diarrhoe erholten, bestand eine Korrelation zu hohen IgG-Titern gegen Toxin B im ELISA-Test und/oder Auftreten von neutralisierenden Antikörpern. Daraus läßt sich schließen, daß die Bestimmung der Antikörper gegenC. difficile-Toxine im Serum mit ELISA in Kombination mit dem herkömmlichen Gewebekultur-Test auf Cytotoxin von diagnostischem Wert ist. Hohe ELISA IgG-Titer gegen Toxin B und/oder das Auftreten neutralisierender Antikörper im Serum können bei Patienten mitC. difficile-Diarrhoe als positives prognostisches Zeichen gewertet werden.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    George, R. H., Symonds, J., Dimock, F., Brown, J. D., Arabi, Y., Shinagawa, N., Keighley, M. R. B., Alexander-Williams, J., Burdon, D. W. Identification ofClostridium difficile as cause of pseudo-membranous colitis. Br. Med. J. 1 (1978) 695.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Bartlett, J. G. Antibiotic-associated pseudomembranous colitis. Rev. Infect. Dis. 1 (1979) 530–539.CrossRefPubMedGoogle Scholar
  3. 3.
    Bartlett, J. G., Tedesco, F. J., Shull, S., Lowe, B., Chang, T.-W. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology 78 (1980) 431–434.PubMedGoogle Scholar
  4. 4.
    George, W. L., Rolfe, R. D., Harding, G. K. M., Klein, R., Putnam, C. W., Finegold, S. M. Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis. Infection 10 (1982) 205–207.CrossRefPubMedGoogle Scholar
  5. 5.
    Sack, D. A. Immune and other defense factors of significance for diarrhoeal diseases: In:Holme, T., Holmgren, J., Merson, M. H., Möllby, R. (eds.): Acute enteric infections in children. Elsevier, Holland 1981, pp. 261–271.Google Scholar
  6. 6.
    Aronsson, B., Granström, M., Möllby, R., Nord, C. E. Enzyme-linked immunosorbent assay (ELISA) for antibodies toClostridium difficile toxins in patients with pseudomembranous colitis and anti-biotic-associated diarrhoea. J. Immunol. Methods 60 (1983) 341–350.CrossRefPubMedGoogle Scholar
  7. 7.
    Ekwall, E., Haeggmann, S., Kalin, M., Svenungsson, B., Lindberg, A. A. Antibody response toShigella sonnei infection determined by an enzyme-linked immunosorbent assay. Eur. J. Clin. Microbiol. 2 (1983) 200–205.CrossRefPubMedGoogle Scholar
  8. 8.
    Aronsson, B., Möllby, R., Nord, C. E. Occurrence of toxin producingClostridium difficile in antibiotic-associated diarrhoea in Sweden. Med. Microbiol. Immunol. 170 (1981) 27–35.CrossRefPubMedGoogle Scholar
  9. 9.
    Libby, J. M., Wilkins, T. D. Production of antitoxins to two toxins ofClostridium difficile and immunological comparison of the toxins by cross-neutralization studies. Infect. Immun. 35 (1982) 374–376.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Aronsson, B., Möllby, R., Nord, C. E. Clostridium difficile and antibiotic-associated diarrhoea in Sweden. Scand. J. Infect. Dis. Suppl. 35 (1982) 53–58.PubMedGoogle Scholar
  11. 11.
    Granström, M., Julander, I., Hedström, S. A., Möllby, R. Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections. J. Clin. Microbiol. 17 (1983) 640–646.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Cremer, N. E. Antibody formation and the immune response. In:Freeman, B. A. (ed.): Burrows textbook of microbiology. 21st ed. The WB Saunders Co., Philadelphia 1979, p. 362.Google Scholar
  13. 13.
    Viscidi, R., Laughon, B. E., Yolken, R., Bo-Linn, R., Moench, T., Ryder, R. W., Bartlett, J. G. Serum antibody response to toxins A and B ofClostridium difficile. J. Infect. Dis. 148 (1983) 93–100.CrossRefPubMedGoogle Scholar
  14. 14.
    George, R. H., Hartley, S. Antibodies toClostridium difficile cytotoxin in a pediatric population. Am. J. Dis. Child. 137 (1983) 1024.PubMedGoogle Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1985

Authors and Affiliations

  • B. Aronsson
    • 1
    • 2
  • M. Granström
    • 1
  • R. Möllby
    • 1
  • C. E. Nord
    • 1
  1. 1.Department of BacteriologyNational Bacteriological LaboratoryStockholm
  2. 2.Department of Infectious Diseases, Karolinska InstituteRoslagstull HospitalStockholm

Personalised recommendations